News

Published on 28 Feb 2024 on Zacks via Yahoo Finance

Inhibrx, Inc. (INBX) Reports Q4 Loss, Tops Revenue Estimates


Article preview image

Inhibrx, Inc. (INBX) came out with a quarterly loss of $1.73 per share versus the Zacks Consensus Estimate of a loss of $1.07. This compares to loss of $0.95 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an earnings surprise of -61.68%. A quarter ago, it was expected that this company would post a loss of $1.01 per share when it actually produced a loss of $1.10, delivering a surprise of -8.91%.

Over the last four quarters, the company has not been able to surpass consensus EPS estimates.

NASDAQ.INBX price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
The recent drop in prices must have disappointed Inhibrx Biosciences, Inc....

Key Insights Given the large stake in the stock by institutions, Inhibrx Biosciences' stock price...

Simply Wall St. · via Yahoo Finance 17 Nov 2024

Inhibrx, Inc. (INBX) Reports Q4 Loss, Tops Revenue Estimates

Inhibrx, Inc. (INBX) came out with a quarterly loss of $1.73 per share versus the Zacks Consensus...

Zacks via Yahoo Finance 28 Feb 2024

The 3 Biotech Stocks That Could Make Your February Unforgettable

Following a hot year of M&A with biotech stocks, we’ll see more of the same in 2024 as drug maker...

InvestorPlace via Yahoo Finance 15 Feb 2024

Biotech Stock Roundup: GILD Down on Study Results, INBX Gains on Sanofi Deal & More

Merger updates and other regulatory news were in focus in the biotech sector ahead of the fourth-...

Zacks via Yahoo Finance 28 Jan 2024

Inhibrx (INBX) Up 6% on Sale of Rare Disease Drug to Sanofi

Inhibrx INBX and Sanofi SNY announced a definitive agreement wherein the latter will acquire the ...

Zacks via Yahoo Finance 21 Jan 2024

Inhibrx, Inc. (INBX) Soars 8.9%: Is Further Upside Left in the Stock?

Inhibrx, Inc. INBX shares ended the last trading session 8.9% higher at $36.30. The jump came on ...

Zacks via Yahoo Finance 21 Jan 2024

12 Best High Risk High Reward Stocks To Buy Now

In this piece, we will take a look at the 12 best high risk high reward stocks to buy now. If you...

Insider Monkey via Yahoo Finance 1 Sep 2023

Why NIO Are Trading Lower By Over 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session By...

Why NIO Are Trading Lower By Over 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Investing.com 29 Aug 2023

Here’s Why Baron Health Care Fund Trimmed AbbVie (ABBV)

Baron Funds, an investment management company, released its “Baron Health Care Fund” first quarte...

Insider Monkey via Yahoo Finance 19 May 2023

Inhibrx, Inc. (INBX) Reports Q1 Loss, Lags Revenue Estimates

Inhibrx, Inc. (INBX) came out with a quarterly loss of $1.12 per share versus the Zacks Consensus...

Zacks via Yahoo Finance 8 May 2023